| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| May 7, 2026 | ±7.1% | -7.2% | under-priced |
| November 10, 2025 | ±9.3% | +0.5% | over-priced |
| August 7, 2025 | ±5.2% | +0.3% | over-priced |
| May 8, 2025 | ±3.9% | +3.6% | over-priced |
| November 12, 2024 | ±7.3% | -0.8% | over-priced |
| August 8, 2024 | ±7.8% | +4.2% | over-priced |
| May 6, 2024 | ±3.8% | +1.5% | over-priced |
| November 8, 2023 | ±5.9% | -3.1% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q1 FY2026 | $-0.07 | $200M | $-45M |
| Q4 FY2025 | $-0.09 | $180M | $-53M |
| Q3 FY2025 | $-0.03 | $155M | $-18M |
| Q2 FY2025 | $-0.13 | $144M | $-66M |
Rocket Lab Corporation Common Stock (RKLB) reports in 98 days, with the next report estimated for September 19, 2026. Across the last 8 reports, options priced an average ±6.3% earnings move while the stock actually moved 2.6% on average — the market has systematically over-priced RKLB's earnings risk. Fundamentals into the print: EPS up 41.7% year-over-year, revenue up 63.5%. QuantLogix's live 5-factor engine currently reads RKLB as a neutral at 48/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →